Today we’re headed into the wild and woolly world of biotech once again, sniffing out the secret stock from a teaser pitch for Biotech Millionaire, edited by Chris Wood and Jake Weber over at Mauldin Economics ($1,795/yr, includes their Healthy Returns letter… and unlike most higher-cost letters these days, they actually offer a 30-day refund […]
High-end newsletter focused on small-cap biotech stocks, using what they call their CASH system to select recommended stocks (Catalysts, large Addressable market, good Science, and a potential Hype story). Wood also edits the “entry level” healthcare investment advisory Healthy Returns.
Robert Ross is peddling his Yield Shark newsletter from Mauldin Economics, and he’s doing it with an all-too-familiar “enroll in this income stream” kind of idea… in his case, he calls it the “Social Security Catastrophe Plan” and implies that it can “Boost Your Retirement by $185,040 Today.” Like most such offerings, there’s an undercurrent […]
New “wealth and wellness” letter from Chris Wood, who has worked on a bunch of investment letters for different publishers, and Dr. Michael Roizen, who is a well-known wellness “guru” and works at the Cleveland Clinic. Aims to provide both stock picks for healthcare-related investments, and health tips for readers.
Several readers have been asking what Tony Sagami’s “Superfood” pitch is all about — this ad started running on Friday, I believe, and it’s a pitch for the Yield Shark newsletter, edited by Sagami and published by Mauldin Economics. And it is blissfully brief in comparison to the many “presentations” we suffer through each day… […]
That’s a subtle headline, right? I already issued a bit of a “brain dump” for the Irregulars this week, on Wednesday instead of Friday, but I couldn’t resist taking a little look at this latest teaser pitch from Patrick Cox for his Transformational Technology Alert. Quite a few readers have been asking about it, and […]
Stock-picking newsletter by the creator of the Dirt Nap daily email for professional traders — aims to pick stocks using contrarian ideas based on investor and consumer trends and “behavioral economics”
Biotech/Emerging Tech Newsletter launched by Patrick Cox in second half of 2013, similar to the early-stage-tech newsletter Breakthrough Technology Alert that he ran for Agora for many years. Often recommends extremely small and speculative stocks.
Newsletter focused on investing for income, aims for “high-yield investments with reasonable risk.” First retail investment newsletter from Mauldin Economics.